PPID expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.375400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.469400E-01
Normal-vs-Stage2
7.584600E-01
Normal-vs-Stage3
2.294200E-01
Normal-vs-Stage4
4.380800E-01
Stage1-vs-Stage2
6.258600E-01
Stage1-vs-Stage3
1.134800E-01
Stage1-vs-Stage4
4.591400E-01
Stage2-vs-Stage3
2.031000E-01
Stage2-vs-Stage4
8.340200E-02
Stage3-vs-Stage4
1.506220E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.674600E-01
Normal-vs-AfricanAmerican
7.610600E-01
Normal-vs-Asian
3.996400E-01
Caucasian-vs-AfricanAmerican
8.581400E-01
Caucasian-vs-Asian
2.764400E-01
AfricanAmerican-vs-Asian
4.270800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.625600E-01
Normal-vs-Female
7.027600E-01
Male-vs-Female
1.498230E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.266200E-01
Normal-vs-Age(41-60Yrs)
6.677000E-01
Normal-vs-Age(61-80Yrs)
7.725400E-01
Normal-vs-Age(81-100Yrs)
9.613000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.621600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.300000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.466800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.165900E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.048600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.211200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.934200E-01
Normal-vs-Daily Drinker
5.740200E-01
Normal-vs-Weekly Drinker
3.318600E-01
Normal-vs-Occasional Drinker
6.282000E-01
Normal-vs-Social Drinker
7.137600E-01
Non Drinker-vs-Daily Drinker
6.830800E-01
Non Drinker-vs-Weekly Drinker
8.851000E-01
Non Drinker-vs-Occasional Drinker
1.220390E-02
Non Drinker-vs-Social Drinker
2.980400E-02
Daily Drinker-vs-Weekly Drinker
6.445200E-01
Daily Drinker-vs-Occasional Drinker
5.628200E-02
Daily Drinker-vs-Social Drinker
1.060570E-01
Weekly Drinker-vs-Occasional Drinker
3.508100E-02
Weekly Drinker-vs-Social Drinker
5.927800E-02
Occasional Drinker-vs-Social Drinker
8.175800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.794800E-01
Normal-vs-Grade 2
5.244600E-01
Normal-vs-Grade 3
7.762100E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.462600E-01
Grade 1-vs-Grade 3
3.739800E-01
Grade 1-vs-Grade 4
2.794800E-01
Grade 2-vs-Grade 3
9.666400E-01
Grade 2-vs-Grade 4
5.244600E-01
Grade 3-vs-Grade 4
7.762100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.123000E-01
Normal-vs-NonDiabetic
9.560600E-01
Diabetic-vs-NonDiabetic
4.191400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.307000E-01
Normal-vs-NoPancreatitis
9.007800E-01
Pancreatitis-vs-NoPancreatitis
3.061400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.425800E-01
Normal-vs-N1
7.835000E-01
N0-vs-N1
2.185400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.706400E-01
Normal-vs-TP53-NonMutant
8.125400E-01
TP53-Mutant-vs-TP53-NonMutant
8.882400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
